Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-001951

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 266,940 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-01-21 Grant or award · Stock Option (right to buy) +153,550 153,550 D
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-01-21 Grant or award · Restricted Stock Units +38,390 38,390 D
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-01-21 Grant or award · Performance Restricted Stock Units +75,000 75,000 D
Loading xslF345X05/form4-01232025_100149.xml…